ABBV Jan 2023 140.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:43PM EDT. Market open.
| Previous close | 9.10 |
| Open | 7.75 |
| Bid | 7.40 |
| Ask | 7.90 |
| Strike | 140.00 |
| Expiry date | 2023-01-20 |
| Day's range | 7.75 - 7.75 |
| Contract range | N/A |
| Volume | |
| Open interest | 4.56k |
- Motley Fool
3 Top Dividend Stocks for Generating Passive Income
One great way to make passive income is to invest in dividend stocks. Here's why they selected AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Merck (NYSE: MRK). Keith Speights (AbbVie): Only the most elite dividend stocks become Dividend Kings.
- Zacks
Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates
The FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and Novartis's (NVS) cancer combination drugs, Tafinlar (dabrafenib) + Mekinist (trametinib).
- PR Newswire
New Survey Offers Perspective on Mental and Emotional Journey for Patients Diagnosed with Slow-Growing Blood Cancer
AbbVie today shared findings from the newly launched Emotional Impact Report, a survey of more than 300 chronic lymphocytic leukemia (CLL) patients, caregivers and healthcare providers (HCPs), which uncovered insights about the emotional journey associated with a CLL diagnosis.
© 2022 Yahoo. All rights reserved.
